Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Shimadzu Introduces C2P Automated Purification/Powderization System

Published: Thursday, May 15, 2014
Last Updated: Thursday, May 15, 2014
Bookmark and Share
Crude2Pure for improved purity, efficiency and productivity.

The field of drug discovery and research has long been complicated by lengthy process times and inefficient operations. Shimadzu Scientific Instruments (SSI) now offers Crude2Pure (C2P), the world’s first automated purification/powderization technology that eliminates time-consuming operations and allows researchers to focus on the crucial tasks of synthesizing and isolating target compounds.

Based on enhanced purification methods, C2P is designed for use with preparative liquid chromatography. The advanced system uses trap concentration to purify target compounds from synthetic products consisting of low molecular weight organic compounds and complicated natural substances, and recovers them as highly pure powders.

This innovative technology allows large-scale, multi-sample processing and will simplify operations, reduce operator workload, and improve productivity in a wide variety of fields, including drug manufacturing, food science, chemistry, government and academic research.

“We are pleased to offer this new technology to greatly enhance research and development projects that require high-quality purification of synthesized target compounds,” said Terry Adams, VP marketing, Shimadzu Scientific Instruments. “This system allows scientists and researchers to more efficiently perform this process, saving time and money for labs, academic institutions and drug developers.”

C2P is the first automated system in the world to accomplish purification of target compounds with high purity and free base resulting in powderized form. The system uses the newly developed Shim-pack C2P-H trapping column to retain target compounds and easily remove only residual components by rinse washing to purify the sample.

Target compounds are recovered “as-is” or as a free base, significantly improving the throughput of biochemical screening and absorption, distribution, metabolism and excretion testing in drug discovery and research.

The system accelerates the sample concentration and powderization process by directly eluting the target compounds retained in the trapping column through a spray nebulizer.

Conventional systems, which employ evaporation to dryness processes, can take as long as 24 hours to complete the process. With C2P, operators can complete the entire process in less than five hours. The system also prevents splashing and contamination problems that occur with conventional processes.

Shimadzu also offers Open Solution Crude2Pure Software, a user-friendly, convenient application that allows operators to set the trap/concentration and powderization operation in three steps. Compatible with an open-access environment, the system allows multiple researchers to share C2P equipment and provides email status notifications to off-site users.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos